Ischemia‐modified albumin in rheumatic diseases: A systematic review and meta‐analysis
Ischemia‐modified albumin in rheumatic diseases: A systematic review and meta‐analysis
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Introduction
The identification of novel, easily measurable disease biomarkers might enhance the diagnosis and management of patients with rheumatic diseases (RDs). We conducted a systematic review and meta‐analysis of ischemia‐modified albumin (IMA), a marker of oxidative stress, acidosis, and ischemia, in RD patients and healthy controls.
M...
Alternative Titles
Full title
Ischemia‐modified albumin in rheumatic diseases: A systematic review and meta‐analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e86048e405ca416b917f18def9dae506
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e86048e405ca416b917f18def9dae506
Other Identifiers
ISSN
2050-4527
E-ISSN
2050-4527
DOI
10.1002/iid3.1324
